APOTHEEK DU FAUX - MERELBEKE financials
A multi-period view of the public annual-account figures reported for APOTHEEK DU FAUX - MERELBEKE, with comparable measures and links to available source documents.
Company overviewRegistry number
0501645495
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for APOTHEEK DU FAUX - MERELBEKE
2025 versus 2024
- Operating line
- €354,852
- EBITDA
- €201,113
- Total assets
- €868,927
- Equity
- €149,416
-15.1%
-17.5%
-0.1%
+19.7%
EBITDA margin +56.7% · Equity ratio +17.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €354,852 | €201,113 | €868,927 | €149,416 | - |
| 202431 Dec 2024 | €417,968 | €243,710 | €869,447 | €124,849 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.